-
Something wrong with this record ?
Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication
L. Hromadkova, ER. Heerdink, D. Philbert, ML. Bouvy,
Language English Country England, Great Britain
Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
PubMed
25311143
DOI
10.1111/ijcp.12544
Knihovny.cz E-resources
- MeSH
- Medication Adherence statistics & numerical data MeSH
- Antipsychotic Agents therapeutic use MeSH
- Adult MeSH
- Cardiovascular Agents therapeutic use MeSH
- Cardiovascular Diseases complications drug therapy MeSH
- Drug Therapy, Combination MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Psychotic Disorders complications drug therapy MeSH
- Aged MeSH
- Health Knowledge, Attitudes, Practice * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Observational Study MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients' beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients' beliefs about and persistence with chronic cardiovascular medication. METHODS: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire - specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. RESULTS: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9-1.5). CONCLUSION: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients' beliefs about medication among those concomitantly using psychiatric drugs.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17001230
- 003
- CZ-PrNML
- 005
- 20170118114207.0
- 007
- ta
- 008
- 170103s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ijcp.12544 $2 doi
- 024 7_
- $a 10.1111/ijcp.12544 $2 doi
- 035 __
- $a (PubMed)25311143
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hromadkova, L $u Department of Clinical Pharmacy, Hospital Na Homolce, Prague, Czech Republic; Division Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
- 245 10
- $a Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication / $c L. Hromadkova, ER. Heerdink, D. Philbert, ML. Bouvy,
- 520 9_
- $a OBJECTIVE: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients' beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients' beliefs about and persistence with chronic cardiovascular medication. METHODS: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire - specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. RESULTS: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9-1.5). CONCLUSION: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients' beliefs about medication among those concomitantly using psychiatric drugs.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antipsychotika $x terapeutické užití $7 D014150
- 650 _2
- $a kardiovaskulární látky $x terapeutické užití $7 D002317
- 650 _2
- $a kardiovaskulární nemoci $x komplikace $x farmakoterapie $7 D002318
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a kombinovaná farmakoterapie $7 D004359
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zdraví - znalosti, postoje, praxe $7 D007722
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a adherence k farmakoterapii $x statistika a číselné údaje $7 D055118
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a psychotické poruchy $x komplikace $x farmakoterapie $7 D011618
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Heerdink, E R
- 700 1_
- $a Philbert, D
- 700 1_
- $a Bouvy, M L
- 773 0_
- $w MED00004893 $t International journal of clinical practice $x 1742-1241 $g Roč. 69, č. 3 (2015), s. 328-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25311143 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170118114314 $b ABA008
- 999 __
- $a ok $b bmc $g 1180370 $s 961797
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 69 $c 3 $d 328-35 $e 20141014 $i 1742-1241 $m International journal of clinical practice $n Int J Clin Pract $x MED00004893
- LZP __
- $a Pubmed-20170103
